Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Status: Enrolling
Updated:  10/30/2017
Tsehootsooi Medical Center
mi
from
Fort Defiance, AZ
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Status: Enrolling
Updated: 10/30/2017
Tsehootsooi Medical Center
mi
from
Fort Defiance, AZ
Click here to add this to my saved trials
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Status: Enrolling
Updated:  10/30/2017
Kayenta Health Center
mi
from
Kayenta, AZ
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Status: Enrolling
Updated: 10/30/2017
Kayenta Health Center
mi
from
Kayenta, AZ
Click here to add this to my saved trials
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Status: Enrolling
Updated:  10/30/2017
Crownpoint Health Center Facility
mi
from
Crownpoint, NM
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Status: Enrolling
Updated: 10/30/2017
Crownpoint Health Center Facility
mi
from
Crownpoint, NM
Click here to add this to my saved trials
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Status: Enrolling
Updated:  10/30/2017
Gallup Indian Medical Center
mi
from
Gallup, NM
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Status: Enrolling
Updated: 10/30/2017
Gallup Indian Medical Center
mi
from
Gallup, NM
Click here to add this to my saved trials
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Status: Enrolling
Updated:  10/30/2017
Northern Navajo Medical Center
mi
from
Shiprock, NM
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Status: Enrolling
Updated: 10/30/2017
Northern Navajo Medical Center
mi
from
Shiprock, NM
Click here to add this to my saved trials
Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults
Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults
Status: Enrolling
Updated:  10/30/2017
University of Arizona Collaboratory for Metabolic Disease Prevention and Treatment
mi
from
Tucson, AZ
Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults
Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults
Status: Enrolling
Updated: 10/30/2017
University of Arizona Collaboratory for Metabolic Disease Prevention and Treatment
mi
from
Tucson, AZ
Click here to add this to my saved trials
Direct Renin Inhibition Effects on Atherosclerotic Biomarkers
Effects of Direct Renin Inhibition on Atherosclerotic Biomarkers in Patients With Stable Coronary Heart Disease and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  10/31/2017
Texas Tech University Health Sciences Center
mi
from
Lubbock, TX
Direct Renin Inhibition Effects on Atherosclerotic Biomarkers
Effects of Direct Renin Inhibition on Atherosclerotic Biomarkers in Patients With Stable Coronary Heart Disease and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 10/31/2017
Texas Tech University Health Sciences Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital
Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital
Status: Enrolling
Updated:  10/31/2017
Winthrop University Hospital
mi
from
Mineola, NY
Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital
Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital
Status: Enrolling
Updated: 10/31/2017
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Egg Ingestion in Adults With Type 2 Diabetes
Egg Ingestion in Adults With Type 2 Diabetes: Effects on Glycemic Control, Anthropometry, Diet Quality and Cardiometabolic Status A Randomized, Controlled, Crossover Trial
Status: Enrolling
Updated:  11/1/2017
Yale-Griffin Prevention Research Center
mi
from
Derby, CT
Egg Ingestion in Adults With Type 2 Diabetes
Egg Ingestion in Adults With Type 2 Diabetes: Effects on Glycemic Control, Anthropometry, Diet Quality and Cardiometabolic Status A Randomized, Controlled, Crossover Trial
Status: Enrolling
Updated: 11/1/2017
Yale-Griffin Prevention Research Center
mi
from
Derby, CT
Click here to add this to my saved trials
Walnut Ingestion in Adults at Risk for Diabetes: Effects on Body Composition, Diet Quality, and Cardiac Risk Measures
Walnut Ingestion in Adults at Risk for Diabetes: Effects on Body Composition, Diet Quality, and Cardiac Risk Measures
Status: Enrolling
Updated:  11/1/2017
Yale-Griffin Prevention Research Center
mi
from
Derby, CT
Walnut Ingestion in Adults at Risk for Diabetes: Effects on Body Composition, Diet Quality, and Cardiac Risk Measures
Walnut Ingestion in Adults at Risk for Diabetes: Effects on Body Composition, Diet Quality, and Cardiac Risk Measures
Status: Enrolling
Updated: 11/1/2017
Yale-Griffin Prevention Research Center
mi
from
Derby, CT
Click here to add this to my saved trials
Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus
A Phase 1, Multiple Ascending Dose Glucose Clamp Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 in Comparison to Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/1/2017
Hanmi Investigative Site
mi
from
Chula Vista, CA
Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus
A Phase 1, Multiple Ascending Dose Glucose Clamp Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 in Comparison to Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/1/2017
Hanmi Investigative Site
mi
from
Chula Vista, CA
Click here to add this to my saved trials
The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects
The Effect of TRADJENTA ® (LINAGLIPTIN) on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects
Status: Enrolling
Updated:  11/2/2017
ECMC Ambulatory Center, 3rd Floor
mi
from
Buffalo, NY
The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects
The Effect of TRADJENTA ® (LINAGLIPTIN) on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects
Status: Enrolling
Updated: 11/2/2017
ECMC Ambulatory Center, 3rd Floor
mi
from
Buffalo, NY
Click here to add this to my saved trials
Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico
Evaluation of a Community Health Worker Intervention on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico
Status: Enrolling
Updated:  11/2/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico
Evaluation of a Community Health Worker Intervention on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico
Status: Enrolling
Updated: 11/2/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
Mesa, AZ
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
Mesa, AZ
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
Hollywood, FL
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
Hollywood, FL
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
Miami, FL
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
Sunset, LA
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
Sunset, LA
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
Oxon Hill, MD
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
Oxon Hill, MD
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
Las Vegas, NV
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
Albuquerque, NM
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
Canal Fulton, OH
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
Canal Fulton, OH
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
Simpsonville, SC
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
Simpsonville, SC
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
San Antonio, TX
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
Burke, VA
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
Burke, VA
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
Buenos Aries,
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
Buenos Aries,
Click here to add this to my saved trials
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/2/2017
GSK Investigational Site
mi
from
Saint Cloud, FL
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/2/2017
GSK Investigational Site
mi
from
Saint Cloud, FL
Click here to add this to my saved trials
Risk Assessment of Long-Haul Truck Drivers
Risk Assessment of Long-Haul Truck Drivers
Status: Enrolling
Updated:  11/3/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Risk Assessment of Long-Haul Truck Drivers
Risk Assessment of Long-Haul Truck Drivers
Status: Enrolling
Updated: 11/3/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Diabetic Shoulder Mobility
Diabetic Upper Extremity Pathophysiology, Limited Joint Mobility and Disability
Status: Enrolling
Updated:  11/3/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Diabetic Shoulder Mobility
Diabetic Upper Extremity Pathophysiology, Limited Joint Mobility and Disability
Status: Enrolling
Updated: 11/3/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet
Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet
Status: Enrolling
Updated:  11/3/2017
Program in Physical Therapy, Washington University in St. Louis
mi
from
Saint Louis, MO
Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet
Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet
Status: Enrolling
Updated: 11/3/2017
Program in Physical Therapy, Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Biospecimens for Identification of Diseases of the Pancreas.
Biospecimens for the Early Detection, Prevention, Diagnosis and Treatment of Diseases of the Pancreas.
Status: Enrolling
Updated:  11/6/2017
Univerisity of Michigan
mi
from
Ann Arbor, MI
Biospecimens for Identification of Diseases of the Pancreas.
Biospecimens for the Early Detection, Prevention, Diagnosis and Treatment of Diseases of the Pancreas.
Status: Enrolling
Updated: 11/6/2017
Univerisity of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Protein, Amino Acids & Insulin & Glucagon Secretion in Humans
The Effect of Ingestion of Foods on the Plasma Glucose and Insulin Response in Subjects With Type 2 Diabetes: Protein, Amino Acids & Insulin & Glucagon Secretion in Humans
Status: Enrolling
Updated:  11/6/2017
Minneapolis VA Health Care System
mi
from
Minneapolis, MN
Protein, Amino Acids & Insulin & Glucagon Secretion in Humans
The Effect of Ingestion of Foods on the Plasma Glucose and Insulin Response in Subjects With Type 2 Diabetes: Protein, Amino Acids & Insulin & Glucagon Secretion in Humans
Status: Enrolling
Updated: 11/6/2017
Minneapolis VA Health Care System
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis
Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis: a Pilot Study to Better Characterize and Standardize the Test
Status: Enrolling
Updated:  11/6/2017
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis
Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis: a Pilot Study to Better Characterize and Standardize the Test
Status: Enrolling
Updated: 11/6/2017
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Feasibility and Efficacy of Delivering Blood Glucose Awareness Training Over the Internet
Blood Glucose Awareness Training Delivered Over the Internet (BGATHome.Com): Feasibility and Efficacy
Status: Enrolling
Updated:  11/6/2017
University of Viginia Health System
mi
from
Charlottesville, VA
Feasibility and Efficacy of Delivering Blood Glucose Awareness Training Over the Internet
Blood Glucose Awareness Training Delivered Over the Internet (BGATHome.Com): Feasibility and Efficacy
Status: Enrolling
Updated: 11/6/2017
University of Viginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Obstructive Sleep Apnea (OSA), Sleepiness, and Activity in Diabetes Management
OSA, Sleepiness, and Activity in Diabetes Management
Status: Enrolling
Updated:  11/6/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Obstructive Sleep Apnea (OSA), Sleepiness, and Activity in Diabetes Management
OSA, Sleepiness, and Activity in Diabetes Management
Status: Enrolling
Updated: 11/6/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
Status: Enrolling
Updated:  11/7/2017
Hanmi pharma
mi
from
Chula Vista, CA
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
Status: Enrolling
Updated: 11/7/2017
Hanmi pharma
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated:  11/7/2017
University of California at San Francisco
mi
from
San Francisco, CA
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated: 11/7/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated:  11/7/2017
University of Miami
mi
from
Miami, FL
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated: 11/7/2017
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated:  11/7/2017
Emory University
mi
from
Atlanta, GA
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated: 11/7/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated:  11/7/2017
Northwestern University
mi
from
Chicago, IL
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated: 11/7/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated:  11/7/2017
Univ of Illinois
mi
from
Chicago, IL
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated: 11/7/2017
Univ of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated:  11/7/2017
Massachusetts General Hospital
mi
from
Boston, MA
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated: 11/7/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated:  11/7/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated: 11/7/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated:  11/7/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Extended Follow-Up After Islet Transplantation in T1D
Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)
Status: Enrolling
Updated: 11/7/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study—STAT Study
Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study—STAT Study
Status: Enrolling
Updated:  11/7/2017
Barbara Davis Center
mi
from
Aurora, CO
Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study—STAT Study
Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study—STAT Study
Status: Enrolling
Updated: 11/7/2017
Barbara Davis Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Chapel Medical Group
mi
from
New Haven, CT
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Chapel Medical Group
mi
from
New Haven, CT
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
MedStar Research Institute
mi
from
Washington,
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
MedStar Research Institute
mi
from
Washington,
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Endocrine Clinical Research
mi
from
Winter Park, FL
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Endocrine Clinical Research
mi
from
Winter Park, FL
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Kaiser Permanente
mi
from
Atlanta, GA
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Kaiser Permanente
mi
from
Atlanta, GA
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Emory School Of Medicine
mi
from
Atlanta, GA
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Emory School Of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials